Clinical Trial Update: To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating inflammatory markers in adults with asthma associated with allergic rhinitis who are treated with montelukast.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED